Cargando…
In-vitro blood-brain barrier models for drug screening and permeation studies: an overview
The blood-brain barrier (BBB) is comprised of brain microvascular endothelial central nervous system (CNS) cells, which communicate with other CNS cells (astrocytes, pericytes) and behave according to the state of the CNS, by responding against pathological environments and modulating disease progre...
Autores principales: | Bagchi, Sounak, Chhibber, Tanya, Lahooti, Behnaz, Verma, Angela, Borse, Vivek, Jayant, Rahul Dev |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805046/ https://www.ncbi.nlm.nih.gov/pubmed/31695329 http://dx.doi.org/10.2147/DDDT.S218708 |
Ejemplares similares
-
Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects
por: Varahachalam, Sree Pooja, et al.
Publicado: (2021) -
Pharmacophore Modeling Using Machine Learning for Screening the Blood–Brain Barrier Permeation of Xenobiotics
por: Kumar, Saurav, et al.
Publicado: (2022) -
Permeation of Dopamine Sulfate through the Blood-Brain Barrier
por: Suominen, Tina, et al.
Publicado: (2015) -
Purinergic signaling: A gatekeeper of blood-brain barrier permeation
por: Wang, Yuemei, et al.
Publicado: (2023) -
Nanostructured Gas Sensors for Health Care: An Overview
por: Kaushik, Ajeet, et al.
Publicado: (2015)